Geode Capital Management, LLC Sio Gene Therapies Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.28 - $0.44 $312 - $491	-1,116 Reduced 0.26%	432,270 $188,000
Q2 2022 Aug 12, 2022	BUY	$0.25 - $0.73 $544 - $1,589	2,178 Added 0.51%	433,386 $156,000
Q4 2021 Feb 11, 2022	BUY	$1.29 - $2.36 $48,251 - $88,273	37,404 Added 9.5%	431,208 $556,000
Q3 2021 Nov 12, 2021	SELL	$1.81 - $2.7 $25,852 - $38,564	-14,283 Reduced 3.5%	393,804 $854,000
Q2 2021 Aug 13, 2021	BUY	$2.07 - $2.89 $745,651 - $1.04 Million	360,218 Added 752.51%	408,087 $1.11 Million
Q4 2020 Feb 12, 2021	BUY	$1.91 - $5.63 $91,429 - $269,502	47,869 New	47,869 $133,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.